173 related articles for article (PubMed ID: 18388356)
1. Acetazolamide for Monge's disease: efficiency and tolerance of 6-month treatment.
Richalet JP; Rivera-Ch M; Maignan M; Privat C; Pham I; Macarlupu JL; Petitjean O; León-Velarde F
Am J Respir Crit Care Med; 2008 Jun; 177(12):1370-6. PubMed ID: 18388356
[TBL] [Abstract][Full Text] [Related]
2. Acetazolamide and N-acetylcysteine in the treatment of chronic mountain sickness (Monge's disease).
Sharma S; Gralla J; Ordonez JG; Hurtado ME; Swenson ER; Schoene RB; Kelly JP; Callacondo D; Rivard C; Roncal-Jimenez C; Sirota J; Fuquay R; Jackson BP; Swenson KE; Johnson RJ; Hurtado A; Escudero E
Respir Physiol Neurobiol; 2017 Dec; 246():1-8. PubMed ID: 28720395
[TBL] [Abstract][Full Text] [Related]
3. Acetazolamide: a treatment for chronic mountain sickness.
Richalet JP; Rivera M; Bouchet P; Chirinos E; Onnen I; Petitjean O; Bienvenu A; Lasne F; Moutereau S; León-Velarde F
Am J Respir Crit Care Med; 2005 Dec; 172(11):1427-33. PubMed ID: 16126936
[TBL] [Abstract][Full Text] [Related]
4. Acetazolamide prevents hypoxic pulmonary vasoconstriction in conscious dogs.
Höhne C; Krebs MO; Seiferheld M; Boemke W; Kaczmarczyk G; Swenson ER
J Appl Physiol (1985); 2004 Aug; 97(2):515-21. PubMed ID: 15247196
[TBL] [Abstract][Full Text] [Related]
5. Effects of iron supplementation and depletion on hypoxic pulmonary hypertension: two randomized controlled trials.
Smith TG; Talbot NP; Privat C; Rivera-Ch M; Nickol AH; Ratcliffe PJ; Dorrington KL; León-Velarde F; Robbins PA
JAMA; 2009 Oct; 302(13):1444-50. PubMed ID: 19809026
[TBL] [Abstract][Full Text] [Related]
6. Acetazolamide fails to decrease pulmonary artery pressure at high altitude in partially acclimatized humans.
Basnyat B; Hargrove J; Holck PS; Srivastav S; Alekh K; Ghimire LV; Pandey K; Griffiths A; Shankar R; Kaul K; Paudyal A; Stasiuk D; Basnyat R; Davis C; Southard A; Robinson C; Shandley T; Johnson DW; Zafren K; Williams S; Weiss EA; Farrar JJ; Swenson ER
High Alt Med Biol; 2008; 9(3):209-16. PubMed ID: 18800957
[TBL] [Abstract][Full Text] [Related]
7. Effect of acetazolamide on ventilatory response in subjects with chronic mountain sickness.
Rivera-Ch M; Huicho L; Bouchet P; Richalet JP; León-Velarde F
Respir Physiol Neurobiol; 2008 Aug; 162(3):184-9. PubMed ID: 18603026
[TBL] [Abstract][Full Text] [Related]
8. Effect of acetazolamide on pulmonary and muscle gas exchange during normoxic and hypoxic exercise.
Jonk AM; van den Berg IP; Olfert IM; Wray DW; Arai T; Hopkins SR; Wagner PD
J Physiol; 2007 Mar; 579(Pt 3):909-21. PubMed ID: 17218362
[TBL] [Abstract][Full Text] [Related]
9. Acetazolamide and chronic hypoxia: effects on haemorheology and pulmonary haemodynamics.
Pichon A; Connes P; Quidu P; Marchant D; Brunet J; Levy BI; Vilar J; Safeukui I; Cymbalista F; Maignan M; Richalet JP; Favret F
Eur Respir J; 2012 Dec; 40(6):1401-9. PubMed ID: 22523353
[TBL] [Abstract][Full Text] [Related]
10. Effects of acetazolamide on cerebrovascular function and breathing stability at 5050 m.
Fan JL; Burgess KR; Thomas KN; Lucas SJ; Cotter JD; Kayser B; Peebles KC; Ainslie PN
J Physiol; 2012 Mar; 590(5):1213-25. PubMed ID: 22219343
[TBL] [Abstract][Full Text] [Related]
11. Possible strategies to reduce altitude-related excessive polycythemia.
Schmidt WFJ; Wachsmuth NB; Romero Pozo MC; Aguilar Valerio MT; Contreras Tapia IC; Vater M; Kaufmann J; Jimenez-Claros JC; Soria R
J Appl Physiol (1985); 2023 Jun; 134(6):1321-1331. PubMed ID: 37055035
[TBL] [Abstract][Full Text] [Related]
12. Renal circulatory effects of acetazolamide in patients with essential hypertension.
Horita Y; Yakabe K; Tadokoro M; Suyama N; Hayashida K; Kawano Y; Miyazaki M; Kohno S; Taura K
Am J Hypertens; 2006 Mar; 19(3):282-5. PubMed ID: 16500514
[TBL] [Abstract][Full Text] [Related]
13. Effect of 5 weeks of oral acetazolamide on patients with pulmonary vascular disease: A randomized, double-blind, cross-over trial.
Lichtblau M; Saxer S; Müller J; Appenzeller P; Berlier C; Schneider SR; Mayer L; Furian M; Schwarz EI; Swenson ER; Bloch KE; Ulrich S
Pulmonology; 2024; 30(4):362-369. PubMed ID: 36639329
[TBL] [Abstract][Full Text] [Related]
14. Acetazolamide to Prevent Adverse Altitude Effects in COPD and Healthy Adults.
Furian M; Mademilov M; Buergin A; Scheiwiller PM; Mayer L; Schneider S; Emilov B; Lichtblau M; Bitos K; Muralt L; Groth A; Reiser AE; Sevik A; Sheraliev U; Marazhapov NH; Aydaralieva S; Muratbekova A; Tabyshova A; Abdraeva A; Buenzli S; Sooronbaev TM; Ulrich S; Bloch KE
NEJM Evid; 2022 Jan; 1(1):EVIDoa2100006. PubMed ID: 38296630
[TBL] [Abstract][Full Text] [Related]
15. Acetazolamide improves cerebral hemodynamics in CADASIL.
Huang L; Yang Q; Zhang L; Chen X; Huang Q; Wang H
J Neurol Sci; 2010 May; 292(1-2):77-80. PubMed ID: 20227091
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic Efficacy of Methazolamide Against Intermittent Hypoxia-Induced Excessive Erythrocytosis in Rats.
Zhang Z; Xiao Z; Deng B; Liu X; Liu W; Nie H; Li X; Chen Z; Yang D; Duan R
High Alt Med Biol; 2018 Mar; 19(1):69-80. PubMed ID: 29077517
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary vasodilation by acetazolamide during hypoxia is unrelated to carbonic anhydrase inhibition.
Höhne C; Pickerodt PA; Francis RC; Boemke W; Swenson ER
Am J Physiol Lung Cell Mol Physiol; 2007 Jan; 292(1):L178-84. PubMed ID: 16936246
[TBL] [Abstract][Full Text] [Related]
18. Chronic mountain sickness and the heart.
León-Velarde F; Villafuerte FC; Richalet JP
Prog Cardiovasc Dis; 2010; 52(6):540-9. PubMed ID: 20417348
[TBL] [Abstract][Full Text] [Related]
19. Serum immunoreactive erythropoietin in high altitude natives with and without excessive erythrocytosis.
León-Velarde F; Monge CC; Vidal A; Carcagno M; Criscuolo M; Bozzini CE
Exp Hematol; 1991 May; 19(4):257-60. PubMed ID: 2055289
[TBL] [Abstract][Full Text] [Related]
20. Acetazolamide reduces exercise capacity and increases leg fatigue under hypoxic conditions.
Garske LA; Brown MG; Morrison SC
J Appl Physiol (1985); 2003 Mar; 94(3):991-6. PubMed ID: 12391068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
